ArticleScientific reports2026
Technical validation of a virtual reality-based eye tracker for neuro-ophthalmic assessment: a reliability and reproducibility study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence-driven virtual reality eye-tracking for the objective measurement of MRD1 and MRD2 in blepharoptosis.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Virtual Reality (VR) eye trackers provide portable and objective tools for neuro-ophthalmic testing. This study aimed to assess the reliability and reproducibility of an emerging VR-based eye tracker (BulbiCAM) in healthy participants and compare its utility to an existing wearable eye-tracking system (PupilLabs Neon), thereby laying the groundwork for the future studies of clinical feasibility. Thirty-nine healthy participants underwent BulbiCAM testing across two visits, with inter-visit reproducibility evaluated using intra-class correlation coefficients. Pupillary light reflex assessments were conducted with both devices, allowing paired comparisons. Participant feedback demonstrated high acceptability, with 89% reporting the test as comfortable and 81.5% experiencing no eye strain or fatigue. BulbiCAM showed high reproducibility for pupil and pursuit tests (ICC = 0.76-0.88), though saccade reproducibility was lower (ICC = 0.46-0.62) which indicates limited reliability for saccade metrics. Key pupillometric parameters showed strong agreement between devices, with minimal bias observed in baseline diameter (-0.48 mm), peak constriction (-0.56 mm), constriction velocity (0.22 mm/s), and duration (-0.052 s). These findings support the potential clinical feasibility and reliability of BulbiCAM for both research and patient testing, offering a promising alternative for objective neuro-ophthalmic assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.